Evidence map›Paper›PMID 37349377›Full record

ArticleNature chemistry2023

Efficient platform for synthesizing comprehensive heparan sulfate oligosaccharide libraries for decoding glycosaminoglycan-protein interactions.

Lei Wang, Alexander W Sorum, Bo-Shun Huang, Mallory K Kern, Guowei Su, Nitin Pawar, Xuefei Huang, Jian Liu, Nicola L B Pohl, Linda C Hsieh-Wilson

Abstract read
In one paragraph

Article in Nature chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Expediting Glycospace Exploration: Therapeutic Glycans via Automated Synthesis.Angewandte Chemie (International ed. in English) · 2025
    Review
  19. Synthesis of Sulfated Carbohydrates - Glycosaminoglycans.Handbook of experimental pharmacology · 2025
    Review
  20. Stereoselective Glycosylation for 1,2-Journal of the American Chemical Society · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Lei WangDivision of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA, USA.
Alexander W SorumDivision of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA, USA.ORCID 0000-0003-2526-1445
Bo-Shun HuangDivision of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA, USA.
Mallory K KernDepartment of Chemistry, Indiana University, Bloomington, IN, USA.
Guowei SuGlycan Therapeutics Corp, Raleigh, NC, USA.
Nitin PawarDivision of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA, USA.
Xuefei HuangDepartments of Chemistry and Biomedical Engineering, Institute for Quantitative Health Science and Engineering, Michigan State University, East Lansing, MI, USA.ORCID 0000-0002-6468-5526
Jian LiuDivision of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA.
Nicola L B PohlDepartment of Chemistry, Indiana University, Bloomington, IN, USA.ORCID 0000-0001-7747-8983
Linda C Hsieh-WilsonDivision of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA, USA. lhw@caltech.edu.ORCID 0000-0001-5661-1714

Funding

Diverse Heparan Sulfate Oligosaccharide Libraries For Understanding and Therapeutically Manipulating GlycosaminoglycansR44GM134738 · NIGMS · GLYCAN THERAPEUTICS CORPORATION · PI PAGADALA, VIJAYAKANTH · 2019 to 2021
$3.2M
Expedited Synthesis of Glycosaminoglycans Containing Defined Sulfation DomainsU01GM116262 · NIGMS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI HSIEH-WILSON, LINDA C, HUANG, XUEFEI · 2015 to 2018
$2.8M
Sugar Building Blocks and Automated Synthesis of Biomedically-Relevant GlycansU01GM116248 · NIGMS · TRUSTEES OF INDIANA UNIVERSITY · PI POHL, NICOLA L. B. · 2015 to 2019
$2.7M
Graduate Training Program in Quantitative and Chemical Biology at Indiana University BloomingtonT32GM131994 · NIGMS · TRUSTEES OF INDIANA UNIVERSITY · PI JARED C LEWIS · 2019 to 2026
$2.4M
Graduate Program in Quantitative and Chemical Biology at Indiana University BloomT32GM109825 · NIGMS · TRUSTEES OF INDIANA UNIVERSITY · PI GIEDROC, DAVID P. · 2014 to 2018
$926k
Construction of chondroitin sulfate microarrayR43GM140693 · NIGMS · GLYCAN THERAPEUTICS CORPORATION · PI SU, GUOWEI · 2022 to 2022
$332k
NIGMS NIH HHS R43 GM140693NIGMS NIH HHS R44 GM134738NIGMS NIH HHS T32 GM109825NIGMS NIH HHS T32 GM131994NIGMS NIH HHS U01 GM116248NIGMS NIH HHS U01 GM116262
6 · The paper itself

Abstract

Glycosaminoglycans (GAGs) are abundant, ubiquitous carbohydrates in biology, yet their structural complexity has limited an understanding of their biological roles and structure-function relationships. Synthetic access to large collections of well defined, structurally diverse GAG oligosaccharides would provide critical insights into this important class of biomolecules and represent a major advance in glycoscience. Here we report a new platform for synthesizing large heparan sulfate (HS) oligosaccharide libraries displaying comprehensive arrays of sulfation patterns. Library synthesis is made possible by improving the overall synthetic efficiency through universal building blocks derived from natural heparin and a traceless fluorous tagging method for rapid purification with minimal manual manipulation. Using this approach, we generated a complete library of 64 HS oligosaccharides displaying all possible 2-O-, 6-O- and N-sulfation sequences in the tetrasaccharide GlcN-IdoA-GlcN-IdoA. These diverse structures provide an unprecedented view into the sulfation code of GAGs and identify sequences for modulating the activities of important growth factors and chemokines.

Indexed as

GlycosaminoglycansHeparan SulfateOligosaccharidesGlycosaminoglycansHeparan SulfateOligosaccharides

Identifiers

PMID37349377
PMCPMC10979459

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.